Civic AI
Procurement intelligence
Federal contract award
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
REVAGENIX INC · Department of Health and Human Services
- Value
- $28,167,401
- Start
- Sep 22, 2022
- End
- Apr 25, 2028
- Action date
- May 6, 2026
- PIID
- 75N93022C00061
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- SAN MATEO, CA
- Award type
- DEFINITIVE CONTRACT
Description
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
Need modifications, related awards, and vendor peers? Open the full award workspace.